About this trial
Long-term observation has shown that patients with visual impairment often develop cognitive impairments. Due to the fact that patients who are planning to undergo corneal transplantation may have initial cognitive deficits, assessing cognitive function is an important aspect of work for both the anesthesiologist and the operating surgeon. Given the high significance of assessing cognitive function after anesthesia in ophthalmic surgery patients, it is relevant to adapt and validate the Russian version of the MoCA Blind test for subsequent use in clinical practice.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
patients with corneal pathology, including burns, ulcers, dystrophies, and keratoectasia, as well as those with a history of corneal injuries
physical status of I-III on the ASA scale.
Disqualifiers
children
patients with sensorineural hearing loss
patients with chronic cerebrovascular disorders
patients with initially high levels of anxiety and depressive symptoms
Trial population
Russian-speaking patients with corneal pathology who are planning a corneal transplant in the future
Trial design
Cohort
Prospective
Treatments tested in this trial
Neurocognitive testing
Diagnostic testThe psychometric properties of the Russian version of the MoCA Blind scale were evaluated according to the following parameters: reliability (reproducibility and internal consistency), validity (content and construct), and sensitivity.
Treatment groups
Trial outcomes
Primary outcomes
postoperative neurocognitive disorders
Postoperative neurocognitive disorders were identified by comparing the results of neuropsychological tests performed before surgery and on the 90th day after surgery. An individual Z-score was used for each domain of the test.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: